Disparities in localized malignant lung cancer surgical treatment: A population‐based cancer registry analysis. (17th November 2022)

• Record Type: Journal Article
• Authors: Mamudu, Lohuwa; Salmeron, Bonita; Odame, Emmanuel A.; Atandoh, Paul H.; Reyes, Joanne L.; Whiteside, Martin; Yang, Joshua; Mamudu, Hadii M.; Williams, Faustine
• Is Part Of: Cancer medicine. Volume 12:Number 6(2023)
• Page Start: 7427
• Page End: 7437
• Publication Date: 2022-11-17
• Subjects: lung cancer -- surgical treatment -- Tennessee -- time to treatment initiation -- treatment disparities; 616.994005
• DOI: 10.1002/cam4.5450
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Background: Lung cancer (LC) continues to be the leading cause of cancer deaths in the United States. Surgical treatment has proven to offer a favorable prognosis and a better 5‐year relative survival for patients with early or localized tumors. This novel study investigates the factors associated with the odds of receiving surgical treatment for localized malignant LC in Tennessee. Methods: Population‐based data of 9679 localized malignant LC patients from the Tennessee Cancer Registry (2005–2015) were utilized to examine the factors associated with receiving surgical treatment for localized malignant LC. Bivariate and multivariate logistic regression analyses, cross‐tabulation, and Chi‐Square ( χ 2 ) tests were conducted to assess these factors. Results: Patients with localized malignant LC who initiated treatment after 2.7 weeks were 46% less likely to receive surgery (adjusted odds ratio [AOR] = 0.54; 95% confidence interval [CI] = 0.50–0.59; p < 0.0001). Females had a greater likelihood (AOR = 1.14; CI = 1.03–1.24) of receiving surgical treatment compared to men. Blacks had lower odds (AOR = 0.76; CI = 0.65–0.98) of receiving surgical treatment compared to Whites. All marital groups had higher odds of receiving surgical treatment compared to those who were single/never married. Patients living in Appalachian county had lower odds of receiving surgical treatment (AOR = 0.65; CI = 0.59–0.71) compared with those in the non‐Appalachian county. Patients with private (AOR = 2.09; CI = 1.55–2.820) or public (AOR = 1.42; CI = 1.06–1.91) insurance coverage were more likely to receive surgical treatment compared to self‐pay/uninsured patients. Overall, the likelihood of patients receiving surgical treatment for localized malignant LC decreases with age. Conclusion: Disparities exist in the receipt of surgical treatment among patients with localized malignant LC in Tennessee. Health policies should target reducing these disparities to improve the survival of these patients. Abstract : Disparities in localized malignant lung cancer surgical treatment: a population‐based cancer registry analysis.